Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

October 2018

Synagis for Upcoming RSV Season

With 2018-2019 respiratory syncytial virus (RSV) season approaching, Harvard Pilgrim would like to remind providers of our policy regarding Synagis (palivizumab), an injection of antibodies used to protect high-risk infants from severe RSV disease.

Synagis requires prior authorization and should be reserved for infants with a history of pre-term birth, and children with chronic lung disease or congenital heart disease. For members who qualify to receive five doses, the first dose is typically administered at the beginning of November and the last dose at the beginning of March to provide protection into April.

Harvard Pilgrim’s preferred specialty vendor, CVS Specialty, will handle dispensing of this medication. To order Synagis, clinicians should complete the appropriate form, found on the Pharmacy prior authorization page on Harvard Pilgrim’s website. Massachusetts and New Hampshire providers will also need to fax a copy of the prescription to CVS Specialty at 800-323-2445, since their state-specific standard forms don’t include a prescription section. However, the form for providers in all other states allows for the capability of including prescription information.

For more information, please visit the Pharmacy section of Harvard Pilgrim’s provider website or call Clinical Pharmacy Services at 617-509-1786.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


Medicare Advantage: Expansion and New Benefits for 2019

CAQH Solution Chosen to Improve Provider Directory Accuracy

Introducing Maine POS and HMO Open Access Plans

SaveOn Program Now Called Reduce My Costs


Updates to Antiemetic Therapy Medical Review Criteria

Updates to Molecular Genetic Testing Clinical Guidelines

Synagis for Upcoming RSV Season


Hospital-Based Clinic and Treatment Room Commercial Payment Policy Updates

2019 CPT and HCPCS codes

Update to Filing Limit for Replacement Claims


Robert Farias,
Senior Vice President, Corporate Network Strategy

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator